J. Lipid Res. Acyl Labeled PIP's available August 1, 2008
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Francone, O. L.
Right arrow Articles by McNeish, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Francone, O. L.
Right arrow Articles by McNeish, J.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Journal of Lipid Research, Vol 38, 813-822, Copyright © 1997 by Lipid Research, Inc.


ARTICLES

Expression of human lecithin:cholesterol acyltransferase in transgenic mice: effects on cholesterol efflux, esterification, and transport

OL Francone, M Haghpassand, JA Bennett, L Royer and J McNeish
Department of Cardiovascular and Metabolic Diseases, Pfizer Inc., Groton, CT 06340, USA.

Human lecithin:cholesterol acyltransferase (LCAT) is a key enzyme in the plasma metabolism of cholesterol and is postulated to participate in a physiologic process called reverse cholesterol transport. We have used transgenic mice expressing the human LCAT transgene to study the effect of increased plasma levels of LCAT in each of the proposed steps involved in the reverse cholesterol transport pathway. High density lipoprotein (HDL) from LCAT transgenic mice was 44% more efficient than control mouse HDL in the efflux of cholesterol from human skin fibroblasts. Esterification of cell-derived cholesterol was also markedly increased in mice expressing the human LCAT transgene. The rate of plasma clearance of HDL cholesteryl ester was virtually the same in both types of animals whereas the HDL cholesteryl ester transport rate was significantly increased in mice expressing the human LCAT transgene (152.3 +/- 16.9 micrograms/h vs. 203.1 +/- 30.9 micrograms/h in control and transgenic mice, respectively). Liver cholesteryl ester uptake was significantly increased in mice expressing human LCAT (58.0 +/- 1.4 micrograms/h/g liver vs. 77.9 +/- 1.7 micrograms/h/g liver in control and transgenic mice, respectively). These studies indicate that LCAT modulates the rate by which cholesterol is effluxed from cell membranes onto HDL, esterified, and transported to the liver.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Lipid Res.Home page
L. Shelly, L. Royer, T. Sand, H. Jensen, and Y. Luo
Phospholipid transfer protein deficiency ameliorates diet-induced hypercholesterolemia and inflammation in mice
J. Lipid Res., April 1, 2008; 49(4): 773 - 781.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. Parathath, Y. F. Darlington, M. de la Llera Moya, D. Drazul-Schrader, D. L. Williams, M. C. Phillips, G. H. Rothblat, and M. A. Connelly
Effects of amino acid substitutions at glycine 420 on SR-BI cholesterol transport function
J. Lipid Res., June 1, 2007; 48(6): 1386 - 1395.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Yvan-Charvet, F. Matsuura, N. Wang, M. J. Bamberger, T. Nguyen, F. Rinninger, X.-C. Jiang, C. L. Shear, and A. R. Tall
Inhibition of Cholesteryl Ester Transfer Protein by Torcetrapib Modestly Increases Macrophage Cholesterol Efflux to HDL
Arterioscler. Thromb. Vasc. Biol., May 1, 2007; 27(5): 1132 - 1138.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Yesilaltay, M. G. Morales, L. Amigo, S. Zanlungo, A. Rigotti, S. L. Karackattu, M. H. Donahee, K. F. Kozarsky, and M. Krieger
Effects of Hepatic Expression of the High-Density Lipoprotein Receptor SR-BI on Lipoprotein Metabolism and Female Fertility
Endocrinology, April 1, 2006; 147(4): 1577 - 1588.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Parathath, M. A. Connelly, R. A. Rieger, S. M. Klein, N. A. Abumrad, M. de la Llera-Moya, C. R. Iden, G. H. Rothblat, and D. L. Williams
Changes in Plasma Membrane Properties and Phosphatidylcholine Subspecies of Insect Sf9 Cells Due to Expression of Scavenger Receptor Class B, Type I, and CD36
J. Biol. Chem., October 1, 2004; 279(40): 41310 - 41318.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Parathath, D. Sahoo, Y. F. Darlington, Y. Peng, H. L. Collins, G. H. Rothblat, D. L. Williams, and M. A. Connelly
Glycine 420 Near the C-terminal Transmembrane Domain of SR-BI Is Critical for Proper Delivery and Metabolism of High Density Lipoprotein Cholesteryl Ester
J. Biol. Chem., June 11, 2004; 279(24): 24976 - 24985.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. A. Connelly, M. de la Llera-Moya, Y. Peng, D. Drazul-Schrader, G. H. Rothblat, and D. L. Williams
Separation of Lipid Transport Functions by Mutations in the Extracellular Domain of Scavenger Receptor Class B, Type I
J. Biol. Chem., July 3, 2003; 278(28): 25773 - 25782.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Wang, M. A. Connelly, A. G. Ostermeyer, H.-h. Chen, D. L. Williams, and D. A. Brown
Caveolin-1 does not affect SR-BI-mediated cholesterol efflux or selective uptake of cholesteryl ester in two cell lines
J. Lipid Res., April 1, 2003; 44(4): 807 - 815.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. A. Connelly, G. Kellner-Weibel, G. H. Rothblat, and D. L. Williams
SR-BI-directed HDL-cholesteryl ester hydrolysis
J. Lipid Res., February 1, 2003; 44(2): 331 - 341.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
H. A. Feister, B. J. Auerbach, L. A. Cole, B. R. Krause, and S. K. Karathanasis
Identification of an IL-6 response element in the human LCAT promoter
J. Lipid Res., June 1, 2002; 43(6): 960 - 970.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
L. Zhou and A. Nilsson
Sources of eicosanoid precursor fatty acid pools in tissues
J. Lipid Res., October 1, 2001; 42(10): 1521 - 1542.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. W. Furbee Jr., O. Francone, and J. S. Parks
Alteration of plasma HDL cholesteryl ester composition with transgenic expression of a point mutation (E149A) of human LCAT
J. Lipid Res., October 1, 2001; 42(10): 1626 - 1635.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. McNeish, R. J. Aiello, D. Guyot, T. Turi, C. Gabel, C. Aldinger, K. L. Hoppe, M. L. Roach, L. J. Royer, J. de Wet, et al.
High density lipoprotein deficiency and foam cell accumulation in mice with targeted disruption of ATP-binding cassette transporter-1
PNAS, April 11, 2000; 97(8): 4245 - 4250.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
P. Holvoet, B. De Geest, S. Van Linthout, M. Lox, S. Danloy, K. Raes, and D. Collen
The Arg123-Tyr166 Central Domain of Human ApoAI Is Critical for Lecithin:Cholesterol Acyltransferase-Induced Hyperalphalipoproteinemia and HDL Remodeling in Transgenic Mice
Arterioscler. Thromb. Vasc. Biol., February 1, 2000; 20(2): 459 - 466.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
B. Foger, M. Chase, M. J. Amar, B. L. Vaisman, R. D. Shamburek, B. Paigen, J. Fruchart-Najib, J. A. Paiz, C. A. Koch, R. F. Hoyt, et al.
Cholesteryl Ester Transfer Protein Corrects Dysfunctional High Density Lipoproteins and Reduces Aortic Atherosclerosis in Lecithin Cholesterol Acyltransferase Transgenic Mice
J. Biol. Chem., December 24, 1999; 274(52): 36912 - 36920.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
H. M. Dansky, S. A. Charlton, J. L. Sikes, S. C. Heath, R. Simantov, L. F. Levin, P. Shu, K. J. Moore, J. L. Breslow, and J. D. Smith
Genetic Background Determines the Extent of Atherosclerosis in ApoE-Deficient Mice
Arterioscler. Thromb. Vasc. Biol., August 1, 1999; 19(8): 1960 - 1968.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
X. Collet, A. R. Tall, H. Serajuddin, K. Guendouzi, L. Royer, H. Oliveira, R. Barbaras, X.-c. Jiang, and O. L. Francone
Remodeling of HDL by CETP in vivo and by CETP and hepatic lipase in vitro results in enhanced uptake of HDL CE by cells expressing scavenger receptor B-I
J. Lipid Res., July 1, 1999; 40(7): 1185 - 1193.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
Y. Ueda, L. Royer, E. Gong, J. Zhang, P. N. Cooper, O. Francone, and E. M. Rubin
Lower Plasma Levels and Accelerated Clearance of High Density Lipoprotein (HDL) and Non-HDL Cholesterol in Scavenger Receptor Class B Type I Transgenic Mice
J. Biol. Chem., March 12, 1999; 274(11): 7165 - 7171.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. L. Hoppe and O. L. Francone
Binding and functional effects of transcription factors Sp1 and Sp3 on the proximal human lecithin:cholesterol acyltransferase promoter
J. Lipid Res., May 1, 1998; 39(5): 969 - 977.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
D. S. Ng, O. L. Francone, T. M. Forte, J. Zhang, M. Haghpassand, and E. M. Rubin
Disruption of the Murine Lecithin:Cholesterol Acyltransferase Gene Causes Impairment of Adrenal Lipid Delivery and Up-regulation of Scavenger Receptor Class B Type I
J. Biol. Chem., June 20, 1997; 272(25): 15777 - 15781.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Ueda, E. Gong, L. Royer, P. N. Cooper, O. L. Francone, and E. M. Rubin
Relationship between Expression Levels and Atherogenesis in Scavenger Receptor Class B, Type I Transgenics
J. Biol. Chem., June 30, 2000; 275(27): 20368 - 20373.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Alam, R. S. Meidell, and D. K. Spady
Effect of Up-regulating Individual Steps in the Reverse Cholesterol Transport Pathway on Reverse Cholesterol Transport in Normolipidemic Mice
J. Biol. Chem., May 4, 2001; 276(19): 15641 - 15649.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Molecular and Cellular Proteomics   ASBMB Today 
Copyright © 1997 by the American Society for Biochemistry and Molecular Biology.